Market Price

174.72 

-0.46 -0.3%

as of Nov 14 '19

52 Week Range:

148.89 259.72


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation/urologics, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 17.16
18.61
20.08
22.13
27.03
28.64
31.51
35.26
39.69
56.50
61.51
growth rate 8.5% 7.9% 10.2% 22.1% 6.0% 10.0% 11.9% 12.6% 42.4% 8.9%
Earnings BIT 36.08
39.15
49.41
66.42
61.84
52.71
44.13
81.87
99.02
137.19
189.02
growth rate 8.5% 26.2% 34.4% -6.9% -14.8% -16.3% 85.5% 21.0% 38.6% 37.8%
Avg.PE 19.88
20.58
16.34
14.27
21.74
24.10
52.92
33.73
43.32
76.23
175.44
growth rate 3.5% -20.6% -12.7% 52.4% 10.9% 119.6% -36.3% 28.4% 76.0% 130.2%
ROA 9.24
8.96
9.96
13.27
10.46
8.71
5.06
7.70
9.48
6.24
1.87
growth rate -3.0% 11.2% 33.2% -21.2% -16.7% -41.9% 52.2% 23.1% -34.2% -70.0%
ROE 10.41
10.25
11.47
15.02
11.61
9.45
5.41
8.27
10.17
7.39
2.34
growth rate -1.5% 11.9% 31.0% -22.7% -18.6% -42.8% 52.9% 23.0% -27.3% -68.3%
ROIC 10.41
10.25
11.47
15.02
11.61
9.45
5.41
8.27
10.17
7.53
2.38
growth rate -1.5% 11.9% 31.0% -22.7% -18.6% -42.8% 52.9% 23.0% -26.0% -68.4%
Cur. Ratio 8.17
6.17
8.07
8.88
11.18
14.67
15.21
11.85
14.03
4.11
3.72
growth rate -24.5% 30.8% 10.0% 25.9% 31.2% 3.7% -22.1% 18.4% -70.7% -9.5%
Quick Ratio 6.84
4.62
5.76
6.94
9.45
12.73
13.43
10.21
12.37
2.47
2.34
growth rate -32.5% 24.7% 20.5% 36.2% 34.7% 5.5% -24.0% 21.2% -80.0% -5.3%
Leverage 1.12
1.17
1.14
1.13
1.10
1.08
1.06
1.08
1.07
1.25
1.25
growth rate 4.5% -2.6% -0.9% -2.7% -1.8% -1.9% 1.9% -0.9% 16.8% 0.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 38.40
47.80
55.10
47.65
53.42
49.67
39.05
57.85
57.18
219.60
201.51
growth rate 24.5% 15.3% -13.5% 12.1% -7.0% -21.4% 48.1% -1.2% 284.1% -8.2%
Acct.Payable 29.31
29.12
26.89
11.38
13.67
14.64
78.23
120.47
growth rate -0.7% -7.7% -57.7% 20.1% 7.1% 434.3% 54.0%
Cur.Assets 179.40
207.90
207.80
260.41
325.50
394.30
432.53
505.01
569.10
864.66
927.04
growth rate 15.9% -0.1% 25.3% 25.0% 21.1% 9.7% 16.8% 12.7% 51.9% 7.2%
Total Assets 283.40
309.20
312.20
361.11
428.51
499.64
541.10
626.83
704.69
1,496.95
1,585.39
growth rate 9.1% 1.0% 15.7% 18.7% 16.6% 8.3% 15.8% 12.4% 112.4% 5.9%
Cash 55.70
51.20
78.90
99.59
146.90
226.02
275.81
336.16
445.08
290.07
344.78
growth rate -8.1% 54.1% 26.2% 47.5% 53.9% 22.0% 21.9% 32.4% -34.8% 18.9%
Inventory 17.90
41.30
44.10
40.42
36.33
34.45
36.93
43.63
49.26
288.66
311.16
growth rate 130.7% 6.8% -8.3% -10.1% -5.2% 7.2% 18.1% 12.9% 485.9% 7.8%
Cur.Liabilities 22.00
33.70
25.80
29.31
29.12
26.89
28.73
42.62
40.54
210.29
249.29
growth rate 53.2% -23.4% 13.6% -0.7% -7.7% 6.9% 48.4% -4.9% 418.8% 18.5%
Liabilities 30.40
44.10
37.90
40.54
37.66
34.92
32.85
46.95
44.53
298.70
321.74
growth rate 45.1% -14.1% 7.0% -7.1% -7.3% -5.9% 42.9% -5.2% 570.7% 7.7%
LT Debt 0.00 0.00 0.00 0.00 0.00
growth rate
Equity 253.00
265.00
274.30
320.58
390.86
464.73
508.25
579.87
660.16
1,198.25
1,263.66
growth rate 4.7% 3.5% 16.9% 21.9% 18.9% 9.4% 14.1% 13.9% 81.5% 5.5%
Common Shares 15.00
15.00
14.00
14.00
15.00
15.00
16.00
16.00
17.00
21.00
22.00
growth rate 0.0% -6.7% 0.0% 7.1% 0.0% 6.7% 0.0% 6.3% 23.5% 4.8%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 11.40
16.70
22.30
15.82
19.16
18.42
16.60
12.98
23.36
74.48
92.72
growth rate 46.5% 33.5% -29.0% 21.1% -3.9% -9.8% -21.8% 79.9% 218.8% 24.5%
Cash Dividends 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 30.20
51.10
33.10
64.49
66.27
65.73
66.34
64.20
89.94
154.42
160.22
growth rate 69.2% -35.2% 94.8% 2.8% -0.8% 0.9% -3.2% 40.1% 71.7% 3.8%
FCF per Share 1.30
2.13
0.72
2.21
3.12
3.00
3.39
2.71
3.15
1.36
4.17
growth rate 63.9% -66.2% 206.9% 41.2% -3.9% 13.0% -20.1% 16.2% -56.8% 206.6%
Sale Purchase of Stock -2.15
17.06
17.43
19.48
17.20
19.71
34.71
growth rate 100.0% 2.1% 11.8% -11.7% 14.6% 76.1%
FCF 19.00
32.00
10.00
49.00
46.00
46.00
43.00
41.00
65.00
75.00
59.00
growth rate 68.4% -68.8% 390.0% -6.1% 0.0% -6.5% -4.7% 58.5% 15.4% -21.3%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 204.70
231.50
283.00
302.20
316.87
313.72
307.36
339.67
379.37
1,292.61
1,400.04
growth rate 13.1% 22.3% 6.8% 4.9% -1.0% -2.0% 10.5% 11.7% 240.7% 8.3%
Op.Income 31.40
38.00
47.70
44.67
41.28
40.42
44.13
81.87
99.02
137.19
189.02
growth rate 21.0% 25.5% -6.4% -7.6% -2.1% 9.2% 85.5% 21.0% 38.6% 37.8%
IBT 36.10
39.10
47.80
66.42
61.84
52.71
39.79
69.70
85.16
51.28
22.37
growth rate 8.3% 22.3% 39.0% -6.9% -14.8% -24.5% 75.2% 22.2% -39.8% -56.4%
Net Income 24.30
26.60
29.90
44.67
41.28
40.42
26.34
44.99
63.08
68.64
28.79
growth rate 9.5% 12.4% 49.4% -7.6% -2.1% -34.8% 70.8% 40.2% 8.8% -58.1%
EPS 1.67
1.77
2.16
3.15
2.80
2.65
1.68
2.73
3.66
3.29
1.33
growth rate 6.0% 22.0% 45.8% -11.1% -5.4% -36.6% 62.5% 34.1% -10.1% -59.6%
Gross Profit 89.80
108.80
129.00
142.35
156.51
154.73
151.40
180.80
201.40
492.40
570.03
growth rate 21.2% 18.6% 10.4% 9.9% -1.1% -2.2% 19.4% 11.4% 144.5% 15.8%
R&D 4.80
2.60
4.70
8.59
10.63
12.41
18.33
15.71
12.96
51.25
52.87
growth rate -45.8% 80.8% 82.7% 23.8% 16.7% 47.8% -14.3% -17.6% 295.6% 3.2%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 54.69
43.34
41.57
49.85
24.85
growth rate -20.8% -4.1% 19.9% -50.2%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 233.87
220.82
201.51
243.28
234.82
growth rate -5.6% -8.7% 20.7% -3.5%
Acct.Payable 91.19
70.57
120.47
133.54
131.19
growth rate -22.6% 70.7% 10.9% -1.8%
Cur.Assets 899.54
913.31
927.04
920.51
929.62
growth rate 1.5% 1.5% -0.7% 1.0%
Total Assets 1,526.34
1,545.18
1,585.39
1,613.27
1,622.92
growth rate 1.2% 2.6% 1.8% 0.6%
Cash 309.10
318.82
344.78
296.04
291.87
growth rate 3.1% 8.1% -14.1% -1.4%
Inventory 288.95
291.84
311.16
321.75
329.96
growth rate 1.0% 6.6% 3.4% 2.6%
Cur.Liabilities 202.47
202.52
249.29
238.41
259.96
growth rate 0.0% 23.1% -4.4% 9.0%
Liabilities 269.28
284.86
321.74
330.58
305.05
growth rate 5.8% 12.9% 2.8% -7.7%
LT Debt 30.64
growth rate
Equity 1,257.07
1,260.31
1,263.66
1,282.69
1,317.86
growth rate 0.3% 0.3% 1.5% 2.7%
Common Shares 2.05
2.05
2.05
2.07
2.07
growth rate 0.2% 0.0% 0.9% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 20.82
27.69
17.66
28.67
20.06
growth rate 33.0% -36.2% 62.3% -30.1%
Cash Dividends
growth rate
Cash From OA 79.69
51.33
49.93
-21.01
23.27
growth rate -35.6% -2.7% -100.0% 100.0%
Sale Purchase of Stock
growth rate
FCF 58.87
23.63
32.27
-49.68
3.21
growth rate -59.9% 36.6% -100.0% 100.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 360.46
327.17
340.38
330.93
312.28
growth rate -9.2% 4.0% -2.8% -5.6%
Op.Income 54.69
43.34
41.57
49.85
24.85
growth rate -20.8% -4.1% 19.9% -50.2%
IBT 29.60
1.44
-12.48
33.43
27.61
growth rate -95.1% -100.0% 100.0% -17.4%
Net Income 31.05
0.22
-7.36
31.00
22.83
growth rate -99.3% -100.0% 100.0% -26.3%
EPS
growth rate
Gross Profit 151.80
134.59
134.64
135.30
103.87
growth rate -11.3% 0.0% 0.5% -23.2%
R&D 13.58
13.18
13.53
12.82
11.20
growth rate -2.9% 2.6% -5.2% -12.7%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (49.45)

YOY Growth Grade:

D (43.88)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 76.71 80.96 22.07
EPS / Growth 25.0% 2.16 16.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 22.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 16.0% 21.1% 21.1%
Future PE 22.07 46.96 46.96
Future EPS 9.52 14.58 14.58
Value Price
MOS %
51.94
-70.3%
169.22
-3.1%
169.22
-3.1%
MOS Price 25.97 84.61 84.61
IRT 16.83 14.19 14.19

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.